Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
GLP-1, Weight Loss Drugs
GLP-1 pills are coming, and they could revolutionize weight-loss treatment
At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing.
Noom to offer compounded GLP-1 drug to rival pricey branded weight loss meds
Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more accessible to consumers. | Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more accessible to consumers.
Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
Digital health company Noom on Thursday announced it will offer a compounded GLP-1 drug as part of a new weight loss product that starts at $149.
Weight Loss Drug Market Goes Wild: 25% of Adults Consider Off-Label Use
A survey reveals 25% of adults are considering using weight loss drugs without a prescription, raising concerns about safety and health risks.
GLP-1 Weight Loss Drugs Used By More Than 15 Million Americans Could Be More Effective With Digital Health Tools
A recent study (1) led by a Stanford Medicine researcher makes one thing clear: No matter which weight loss tactic a patient uses, they are typically more successful if they track their progress with digital health tools.
Another digital healthcare company is selling off-brand weight loss drugs — for pretty cheap
The psychology-based digital healthcare platform Noom announced Thursday that is now offering off-brand weight loss drugs for one of the cheapest starting prices in the industry.
Medscape
2d
Semaglutide Bests Liraglutide in Long-Term Weight Loss
Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...
WJW-TV Cleveland on MSN
8h
Does Ozempic work for long-term weight loss? New study says yes
A new medical study published this month suggests yes — with some key factors to keep in mind. Ozempic’s long-term impact.
1d
Does ‘nature’s Ozempic’ really work? Trendy GLP-1 supplements are designed to supercharge weight loss for a fraction of the price
Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...
3d
Achieving Weight Loss: New Study Identifies Key Factors of Success
The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...
Science Daily
8d
Key factors that impact long-term weight loss in patients prescribed GLP-1 RA medications
A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...
STAT
9d
Compounded semaglutide is an ill-defined public health crisis
Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...
3d
Hims & Hers offers compounded Wegovy for $99 a month to select professions
U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...
6d
A cure for Tennessee's obesity epidemic? Weight-loss drugs spur overdoses, competition
More Tennessee companies are covering weight-loss injections in health care benefit plans. This could impact the state's high ...
3d
on MSN
Maker of Ozempic, Wegovy sues Minnesota clinic over knockoff weight-loss medication
One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback